There’s a reason orthopedic care still feels like a bad remix of 1997 healthcare. Everyone’s still paging each other like it’s ER, triaging by guesswork, and drowning in follow-up calls that should’ve been AI’d three years ago. Enter RevelAi Health, the company making sure musculoskeletal care doesn’t limp into the future.
Just locked in a $3.1M oversubscribed seed round, RevelAi Health is putting conversational AI to work where it’s desperately needed, the $420B musculoskeletal market that’s been living rent-free in the healthcare system’s blind spot. And this isn’t your average health tech fluff. We’re talking enterprise-grade, SOC2 Type2 certified, multilingual, EHR integrated tech that’s automating thousands of clinical conversations, slicing post-op call times, and giving providers back almost a full workday for every 100 patients.
Led by Christian Pean, MD, MS, orthopedic trauma surgeon, faculty at Duke-Margolis, and the kind of operator who can scrub in and spin policy in the same breath, and Hadi Javeed, a CTO who’s spent the last decade building AI systems that actually work in the mess that is real-world care, RevelAi isn’t just coding workflows, they’re building out a new category.
Investors noticed. Ulu Ventures and Symphonic Capital led the charge, joined by Orthopedic VC, Sand Hill Angels, and a heavyweight squad of nationally recognized orthopedic surgeons who don’t back vaporware. And if you’re wondering whether the orthopedic old guard is buying in, check the multi-year co-marketing agreement with Zimmer Biomet, and clinical partnerships with NYU Langone Health, LifeBridge Health, and Samimi Orthopedic Group. This isn’t a pilot graveyard, it’s proof.
RevelAi’s secret sauce? Kimi, their 24/7 AI agent, isn’t just answering phones, she’s collecting CMS-aligned quality data, documenting visits ambiently, handling TCM/PCM workflows, and translating clinical complexity into structured notes that don’t suck. This is orchestration at scale, not a digital Band-Aid.
The funding is going to deepen integrations, expand outcome pathways, and scale the team that’s already proven they can go toe-to-toe with legacy EHR vendors and win. And with CMS nudging the market into mandatory downside-risk bundles, the timing couldn’t be sharper.
Christian Pean, MD, MS and Hadi Javeed are building for the orthopedic future, the kind where equity, efficiency, and reimbursement finally sync. And they’re not shouting about transformation. They’re engineering it, one structured note and triaged patient at a time.
